EUVIMEDEUVIMED entdecken
Crossref

Molecular and clinical interactions between gut microbiota and endothelial dysfunction: A review of mechanisms and therapeutic perspectives

Steliana Simona Tudor, Claudia Simona Stefan, Caterina Nela Dumitru, Ancuta Iacob, Ionela Daniela Fertu

Electronic Journal of General Medicine · 15.07.2026 · 23 (4) · em743

DOI: 10.29333/ejgm/18972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Electronic Journal of General Medicine, erschienen am 15.07.2026. Verfasst von Steliana Simona Tudor und 4 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases remain the leading cause of mortality worldwide, accounting for approximately 32% of all deaths recorded in 2022, according to data provided by the World Health Organization. Although traditional risk factors are well known, a significant proportion of residual cardiovascular risk remains unexplained. Over the last decade, the gut microbiota has gained interest as an essential regulator of metabolic and immune homeostasis, and the concept of “gut-heart axis” has gained increasing attention in medical literature. This review aims to synthesize the current evidence we have linking gut dysbiosis to endothelial dysfunction in various vascular pathologies. It will analyze the molecular mechanisms through which microbiota-derived metabolites such as trimethylamine-N-oxide (TMAO), short-chain fatty acids, and bacterial lipopolysaccharides modulate nitric oxide bioavailability, vascular inflammation, and oxidative stress. Furthermore, the paper discusses the clinical implications of these interactions and the potential of therapeutic strategies based on microbiome modulation through probiotics, prebiotics, or fecal transplant in restoring proper endothelial function. Understanding the complexity of this axis and the gut-heart interactions offers valuable insights for personalized medicine and cardiovascular prevention. This review brings novelty by integrating recent molecular and clinical evidence on the gut-heart axis, highlighting microbiota-derived metabolites as potential therapeutic targets.

Zitieren

APA

Tudor, S. S., Stefan, C. S., Dumitru, C. N., Iacob, A., & Fertu, I. D. (2026). Molecular and clinical interactions between gut microbiota and endothelial dysfunction: A review of mechanisms and therapeutic perspectives. Electronic Journal of General Medicine, 23(4), em743. https://doi.org/10.29333/ejgm/18972

Vancouver

Tudor SS, Stefan CS, Dumitru CN, Iacob A, Fertu ID. Molecular and clinical interactions between gut microbiota and endothelial dysfunction: A review of mechanisms and therapeutic perspectives. Electronic Journal of General Medicine. 2026;23(4):em743. doi:10.29333/ejgm/18972

BibTeX
@article{Tudor2026,
  author = {Tudor, Steliana Simona and Stefan, Claudia Simona and Dumitru, Caterina Nela and Iacob, Ancuta and Fertu, Ionela Daniela},
  title = {Molecular and clinical interactions between gut microbiota and endothelial dysfunction: A review of mechanisms and therapeutic perspectives},
  journal = {Electronic Journal of General Medicine},
  year = {2026},
  volume = {23},
  number = {4},
  pages = {em743},
  doi = {10.29333/ejgm/18972}
}
Kostenlos starten →